Twist Bioscience Corporation (TWST) Q1 2020 Earnings Results

Twist Bioscience Misses on EPS, Stock Up 16.3%

Twist Bioscience's earnings report showed a significant loss per share, but the stock reacted positively, rising 16.3%. This increase may be attributed to investor confidence in the company's long-term growth strategy and ongoing investments in research and development. The lack of revenue details and guidance suggests uncertainty, but the market seems to be optimistic about future prospects.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-1.69	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed cautious optimism about the company's future growth potential. They are committed to investing in research and development to enhance their product offerings.

Management highlighted ongoing investments in R&D to drive future growth.

They acknowledged challenges but emphasized a strong pipeline of products.

Focus remains on expanding market presence despite current losses.

Twist Bioscience Misses on EPS, Stock Up 16.3%

Key numbers

Management commentary

Twist Bioscience Corporation

More earnings this week

Twist Bioscience Misses on EPS, Stock Up 16.3%

Key numbers

Management commentary